Quest Diagnostics Incorporated (DGX)
Healthcare • Diagnostics & Research
StockNYSEUnited StatesUS74834L1008
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Quest Diagnostics Incorporated, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 16:26. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 09 Feb 2027 08:00 | 2.68 | — | — | Upcoming |
| 22 Oct 2026 06:00 | 2.87 | 3.00 | +4.4% | Beat |
| 23 Jul 2026 06:00 | 2.82 | 3.12 | +10.5% | Beat |
| 21 Apr 2026 06:00 | 2.37 | 2.50 | +5.6% | Beat |
| 10 Feb 2026 06:00 | 2.36 | 2.42 | +2.6% | Beat |
| 21 Oct 2025 06:00 | 2.50 | 2.60 | +3.9% | Beat |
| 22 Jul 2025 06:00 | 2.57 | 2.62 | +1.9% | Beat |
| 22 Apr 2025 06:00 | 2.15 | 2.21 | +2.8% | Beat |
| 30 Jan 2025 06:00 | 2.18 | 2.23 | +2.1% | Beat |
| 22 Oct 2024 06:00 | 2.26 | 2.30 | +1.9% | Beat |
| 23 Jul 2024 06:00 | 2.33 | 2.35 | +0.7% | In line |
| 23 Apr 2024 06:00 | 1.86 | 2.04 | +9.8% | Beat |
| 01 Feb 2024 06:00 | 2.11 | 2.15 | +1.7% | Beat |
| 24 Oct 2023 06:00 | 2.19 | 2.22 | +1.4% | Beat |
| 26 Jul 2023 06:00 | 2.26 | 2.30 | +1.9% | Beat |
| 27 Apr 2023 06:00 | 1.97 | 2.04 | +3.5% | Beat |
| 02 Feb 2023 06:00 | 1.90 | 1.98 | +4.0% | Beat |
| 20 Oct 2022 06:00 | 2.19 | 2.36 | +7.6% | Beat |
| 21 Jul 2022 06:00 | 2.27 | 2.36 | +3.9% | Beat |
| 21 Apr 2022 06:00 | 3.00 | 3.22 | +7.3% | Beat |
| 03 Feb 2022 06:00 | 3.21 | 3.33 | +3.8% | Beat |
| 21 Oct 2021 06:00 | 3.06 | 3.96 | +29.2% | Beat |
| 22 Jul 2021 06:00 | 2.86 | 3.18 | +11.1% | Beat |
| 22 Apr 2021 06:00 | 3.73 | 3.76 | +0.7% | In line |
| 04 Feb 2021 06:00 | 4.24 | 4.48 | +5.7% | Beat |
| 22 Oct 2020 06:00 | 3.73 | 4.31 | +15.6% | Beat |
| 23 Jul 2020 06:00 | 1.25 | 1.42 | +13.5% | Beat |
| 22 Apr 2020 07:00 | 0.88 | 0.94 | +6.7% | Beat |
| 30 Jan 2020 06:00 | 1.60 | 1.67 | +4.2% | Beat |
| 22 Oct 2019 06:00 | 1.71 | 1.76 | +2.9% | Beat |
| 23 Jul 2019 06:00 | 1.68 | 1.73 | +2.8% | Beat |
| 23 Apr 2019 06:00 | 1.38 | 1.40 | +1.7% | Beat |
| 14 Feb 2019 06:00 | 1.37 | 1.36 | -0.6% | In line |
| 23 Oct 2018 06:00 | 1.68 | 1.68 | +0.2% | In line |
| 24 Jul 2018 06:00 | 1.76 | 1.75 | -0.3% | In line |
| 19 Apr 2018 06:00 | 1.50 | 1.52 | +1.2% | Beat |
| 01 Feb 2018 06:00 | 1.37 | 1.40 | +1.9% | Beat |
| 19 Oct 2017 06:00 | 1.36 | 1.39 | +2.6% | Beat |
| 25 Jul 2017 06:00 | 1.42 | 1.55 | +9.5% | Beat |
| 20 Apr 2017 06:00 | 1.18 | 1.33 | +13.2% | Beat |
| 26 Jan 2017 06:00 | 1.27 | 1.31 | +3.0% | Beat |
| 20 Oct 2016 06:00 | 1.35 | 1.37 | +1.3% | Beat |
| 21 Jul 2016 06:00 | 1.32 | 1.34 | +1.8% | Beat |
| 21 Apr 2016 06:00 | 1.12 | 1.12 | +0.1% | In line |
| 28 Jan 2016 06:00 | 1.19 | 1.19 | +0.1% | In line |
| 22 Oct 2015 06:00 | 1.26 | 1.28 | +1.6% | Beat |
| 23 Jul 2015 07:00 | 1.23 | 1.25 | +1.2% | Beat |
| 23 Apr 2015 07:00 | 1.04 | 1.05 | +0.8% | In line |
| 29 Jan 2015 07:00 | 1.05 | 1.08 | +3.2% | Beat |
| 23 Oct 2014 07:00 | 1.08 | 1.10 | +2.3% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 11B | +11.8% | 992M | 9.0% | 8.75 | +13.8% | 1.4B |
| 2024 | 9.9B | +6.7% | 871M | 8.8% | 7.69 | +2.7% | 909M |
| 2023 | 9.3B | -6.4% | 854M | 9.2% | 7.49 | -6.0% | 864M |
| 2022 | 9.9B | — | 946M | 9.6% | 7.97 | — | 1.3B |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 251.60 | 262.00 | 244.58 | 260.39 | +3.41% | 8,376,227 | |
| Oct 2026 | 232.74 | 256.99 | 223.50 | 251.82 | +8.04% | 22,884,300 | 0.8600 |
| Sep 2026 | 242.72 | 248.84 | 227.24 | 233.07 | -3.01% | 23,704,100 | |
| Aug 2026 | 232.84 | 247.19 | 229.76 | 240.30 | +3.13% | 16,944,400 | |
| Jul 2026 | 213.67 | 240.13 | 201.00 | 233.01 | +9.94% | 24,374,700 | 0.8600 |
| Jun 2026 | 194.14 | 214.21 | 191.02 | 211.95 | +8.75% | 18,542,700 | |
| May 2026 | 194.50 | 197.38 | 186.23 | 194.90 | +0.36% | 15,591,900 | |
| Apr 2026 | 195.51 | 209.79 | 187.50 | 194.20 | -0.91% | 22,129,300 | 0.8600 |
| Mar 2026 | 212.52 | 213.26 | 192.73 | 195.98 | -7.52% | 18,688,200 | |
| Feb 2026 | 186.01 | 213.50 | 182.36 | 211.91 | +13.30% | 22,181,000 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- Quest Diagnostics (NYSE:DGX): A Quality Dividend Stock for Income Investors (opens in a new tab) ChartMill · 12 Nov 2026 12:30
- What Happened To People Who Bought Quest Stock At A High? (opens in a new tab) Trefis · 11 Nov 2026 17:41
- Quest Diagnostics Declares Quarterly Cash Dividend (opens in a new tab) 10 Nov 2026 21:06
- Quest Diagnostics to Speak at the 9th Annual Evercore Healthcare Conference (opens in a new tab) 09 Nov 2026 17:40
- Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference in London (opens in a new tab) 09 Nov 2026 17:38
- Global Cardiovascular Genetic Testing Market Report 2026 | Capitalize on 11% CAGR and AI Genomics with Labcorp, Quest Diagnostics, Illumina, and Fulgent Genetics (opens in a new tab) 09 Nov 2026 14:08
- IBD Stock Of The Day Quest Diagnostics Is Bucking The Medtech Malaise (opens in a new tab) Investor's Business Daily · 06 Nov 2026 21:57
- Subu Ramachandran Expands Holdings With Quest Diagnostics Stock Options Worth $6K (opens in a new tab) Benzinga · 06 Nov 2026 11:01
- EBay Leads Five Stocks Near Buy Points From Resilient Sectors (opens in a new tab) Investor's Business Daily · 31 Oct 2026 12:00
- Labcorp, Quest urge RESULTS Act passage as lab payment cuts loom (opens in a new tab) MedTech Dive · 30 Oct 2026 14:47
- Quest Diagnostics (DGX) Stock Price Stalls After Strong Q3 Earnings (opens in a new tab) Simply Wall St. · 24 Oct 2026 04:14
- Quest Diagnostics (DGX) Backs At Home Cervical Cancer Screening (opens in a new tab) Simply Wall St. · 24 Oct 2026 00:12
- Quest Diagnostics (DGX) Stock Could Be Undervalued Despite Raised Full Year Guidance (opens in a new tab) Simply Wall St. · 23 Oct 2026 18:15
- Lab testing giant Quest Diagnostics confirms patients’ personal and health data was compromised during breach (opens in a new tab) TechCrunch · 23 Oct 2026 16:00
- Was Quest's 'Good Enough' Third Quarter Actually Good Enough? (opens in a new tab) Investor's Business Daily · 22 Oct 2026 21:21
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 259.65 USD
- Market cap
- 28.6B
- Dividend yield
- 1.32%
- 5-year average yield
- 1.81%
- Payout ratio
- 25%
- Last dividend
- 0.8600 USD · 12 Jan 2027
- Next ex-dividend date
- 12 Jan 2027
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Currency
- USD
Dividends
| Ex-dividend date | Per share |
|---|---|
| 06 Oct 2026 | 0.8600 USD |
| 08 Jul 2026 | 0.8600 USD |
| 06 Apr 2026 | 0.8600 USD |
| 13 Jan 2026 | 0.8000 USD |
| 8 older dividends: create a free account to see them | |
Why this score
Similar shares
Follow DGX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.